Is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions?

Abstract Background Total gastrectomy (TG) is a widely accepted procedure for treating gastric stump cancer (GSC). However, subtotal gastrectomy (SG) would benefit elective patients with GSC. The aim of this study was to clarify the safety and long-term prognosis of SG in treating GSC after distal g...

Full description

Bibliographic Details
Main Authors: Fuhai Ma, Yang Li, Weikun Li, Wenzhe Kang, Hao Liu, Shuai Ma, Bingzhi Wang, Yibin Xie, Yuxin Zhong, Yingtai Chen, Liyan Xue, Yantao Tian
Format: Article
Language:English
Published: BMC 2020-02-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12957-020-01821-y
_version_ 1818029474263859200
author Fuhai Ma
Yang Li
Weikun Li
Wenzhe Kang
Hao Liu
Shuai Ma
Bingzhi Wang
Yibin Xie
Yuxin Zhong
Yingtai Chen
Liyan Xue
Yantao Tian
author_facet Fuhai Ma
Yang Li
Weikun Li
Wenzhe Kang
Hao Liu
Shuai Ma
Bingzhi Wang
Yibin Xie
Yuxin Zhong
Yingtai Chen
Liyan Xue
Yantao Tian
author_sort Fuhai Ma
collection DOAJ
description Abstract Background Total gastrectomy (TG) is a widely accepted procedure for treating gastric stump cancer (GSC). However, subtotal gastrectomy (SG) would benefit elective patients with GSC. The aim of this study was to clarify the safety and long-term prognosis of SG in treating GSC after distal gastrectomy for benign lesions. Methods A total of 53 patients with GSC located at the anastomotic site or gastric body between May 1999 and December 2018 at our hospital were included. In total, 21 patients underwent SG, and the remaining 24 patients underwent TG. Clinicopathological data, operative data, and overall survival (OS) were compared. Results The operative duration, estimated blood loss volume, and length of hospital stay were similar between the SG and TG groups. The postoperative complications were similar between the two groups, but no cases of anastomotic leakage were noted in the SG group. TG was associated with significantly more retrieved lymph nodes than SG (18.5 ± 11.5 vs. 10.7 ± 9.2; p = 0.017), while the number of metastatic lymph nodes did not differ between the groups (2.9 ± 3.5 vs. 1.9 ± 3.6; p = 0.329). The median survival time in the SG group was 81.0 months (95% confidence interval (CI), 68.906 to 93.094 months), which was similar to the 45.0 months (95% CI, 15.920 to 74.080 months) observed in the TG group (p = 0.236). Both univariate and multivariate analyses showed that tumor location and histological type were prognostic factors, while surgery type was not a prognostic factor. Further stratified analyses according to tumor location revealed that OS was not significantly different between the two groups among patients with tumors located at the anastomotic site, while OS in the TG group was significantly better than that in the SG group among patients with tumors located in the gastric body (p = 0.046). Conclusions The results of the current study indicate that SG is a suitable alternative surgical procedure for GSC located at the anastomotic site after distal gastrectomy for benign lesions. The short-term outcomes and long-term prognoses of SG are comparable with those of TG.
first_indexed 2024-12-10T05:20:16Z
format Article
id doaj.art-458f882fb54a49dcbda4928ce58fceb4
institution Directory Open Access Journal
issn 1477-7819
language English
last_indexed 2024-12-10T05:20:16Z
publishDate 2020-02-01
publisher BMC
record_format Article
series World Journal of Surgical Oncology
spelling doaj.art-458f882fb54a49dcbda4928ce58fceb42022-12-22T02:00:50ZengBMCWorld Journal of Surgical Oncology1477-78192020-02-011811810.1186/s12957-020-01821-yIs subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions?Fuhai Ma0Yang Li1Weikun Li2Wenzhe Kang3Hao Liu4Shuai Ma5Bingzhi Wang6Yibin Xie7Yuxin Zhong8Yingtai Chen9Liyan Xue10Yantao Tian11Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeAbstract Background Total gastrectomy (TG) is a widely accepted procedure for treating gastric stump cancer (GSC). However, subtotal gastrectomy (SG) would benefit elective patients with GSC. The aim of this study was to clarify the safety and long-term prognosis of SG in treating GSC after distal gastrectomy for benign lesions. Methods A total of 53 patients with GSC located at the anastomotic site or gastric body between May 1999 and December 2018 at our hospital were included. In total, 21 patients underwent SG, and the remaining 24 patients underwent TG. Clinicopathological data, operative data, and overall survival (OS) were compared. Results The operative duration, estimated blood loss volume, and length of hospital stay were similar between the SG and TG groups. The postoperative complications were similar between the two groups, but no cases of anastomotic leakage were noted in the SG group. TG was associated with significantly more retrieved lymph nodes than SG (18.5 ± 11.5 vs. 10.7 ± 9.2; p = 0.017), while the number of metastatic lymph nodes did not differ between the groups (2.9 ± 3.5 vs. 1.9 ± 3.6; p = 0.329). The median survival time in the SG group was 81.0 months (95% confidence interval (CI), 68.906 to 93.094 months), which was similar to the 45.0 months (95% CI, 15.920 to 74.080 months) observed in the TG group (p = 0.236). Both univariate and multivariate analyses showed that tumor location and histological type were prognostic factors, while surgery type was not a prognostic factor. Further stratified analyses according to tumor location revealed that OS was not significantly different between the two groups among patients with tumors located at the anastomotic site, while OS in the TG group was significantly better than that in the SG group among patients with tumors located in the gastric body (p = 0.046). Conclusions The results of the current study indicate that SG is a suitable alternative surgical procedure for GSC located at the anastomotic site after distal gastrectomy for benign lesions. The short-term outcomes and long-term prognoses of SG are comparable with those of TG.http://link.springer.com/article/10.1186/s12957-020-01821-yGastric stump cancerAnastomotic siteSubtotal gastrectomyTotal gastrectomy
spellingShingle Fuhai Ma
Yang Li
Weikun Li
Wenzhe Kang
Hao Liu
Shuai Ma
Bingzhi Wang
Yibin Xie
Yuxin Zhong
Yingtai Chen
Liyan Xue
Yantao Tian
Is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions?
World Journal of Surgical Oncology
Gastric stump cancer
Anastomotic site
Subtotal gastrectomy
Total gastrectomy
title Is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions?
title_full Is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions?
title_fullStr Is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions?
title_full_unstemmed Is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions?
title_short Is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions?
title_sort is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions
topic Gastric stump cancer
Anastomotic site
Subtotal gastrectomy
Total gastrectomy
url http://link.springer.com/article/10.1186/s12957-020-01821-y
work_keys_str_mv AT fuhaima issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions
AT yangli issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions
AT weikunli issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions
AT wenzhekang issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions
AT haoliu issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions
AT shuaima issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions
AT bingzhiwang issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions
AT yibinxie issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions
AT yuxinzhong issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions
AT yingtaichen issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions
AT liyanxue issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions
AT yantaotian issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions